Xiaoling H. Lu

22 Shuang Yong Rd
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications

Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment.

Dual-modular-nanobody CAR-T cell technical platform against the solid tumor microenvironment.

Journal: Journal of hematology & oncology
Published: March 05, 2026

TCR-mimic bispecific nanobody-based T cell engager targeting intracellular tumor antigens for cancer immunotherapy.

TCR-mimic bispecific nanobody-based T cell engager targeting intracellular tumor antigens for cancer immunotherapy.

Journal: Signal transduction and targeted therapy
Published: October 16, 2025

Correction to: Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells.

Correction to: Aptamer-Functionalized Fluorescent Silica Nanoparticles for Highly Sensitive Detection of Leukemia Cells.

Journal: Discover nano
Published: October 01, 2025

Editor's Note: Tumor Imaging and Interferon-γ-Inducible Protein-10 Gene Transfer Using a Highly Efficient Transferrin-Conjugated Liposome System in Mice.

Editor's Note: Tumor Imaging and Interferon-γ-Inducible Protein-10 Gene Transfer Using a Highly Efficient Transferrin-Conjugated Liposome System in Mice.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 29, 2025

Correction to: Aptamer combined with fluorescent silica nanoparticles for detection of hepatoma cells.

Correction to: Aptamer combined with fluorescent silica nanoparticles for detection of hepatoma cells.

Journal: Discover nano
Published: August 25, 2025

Author Correction: Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.

Author Correction: Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity.

Journal: Scientific reports
Published: July 23, 2025

Corrigendum to "Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer" [Neoplasia. 2014 Aug;16(8):665-77].

Corrigendum to "Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer" [Neoplasia. 2014 Aug;16(8):665-77].

Journal: Neoplasia (New York, N.Y.)
Published: May 09, 2025

Dendritic cell vaccines: Current research progress, challenges, and opportunities.

Dendritic cell vaccines: Current research progress, challenges, and opportunities.

Journal: Genes & diseases
Published: March 13, 2025

Nanobody-based drug delivery systems for cancer therapy.

Nanobody-based drug delivery systems for cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 11, 2024

Research trends in the use of nanobodies for cancer therapy.

Research trends in the use of nanobodies for cancer therapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 15, 2024

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.

A nanobody-guided multifunctional T cell engager promotes strong anti-tumor responses via synergistic immuno-photothermal effects.

Journal: Journal of nanobiotechnology
Published: April 30, 2024

A novel anti-CTLA-4 nanobody-IL12 fusion protein in combination with a dendritic cell/tumour fusion cell vaccine enhances the antitumour activity of CD8+ T cells in solid tumours.

A novel anti-CTLA-4 nanobody-IL12 fusion protein in combination with a dendritic cell/tumour fusion cell vaccine enhances the antitumour activity of CD8+ T cells in solid tumours.

Journal: Journal of nanobiotechnology
Published: November 09, 2023
Showing 1-12 of 76

Last Updated: 09/26/2026